Update: Syringe Exchange Programs - United States, 1997

Morbidity and Mortality Weekly Report

Volumn 47, Issue 31, 1998, Pages 652-655

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; PREVENTIVE HEALTH SERVICE; STATISTICS; UNITED STATES;

HUMANS; NEEDLE-EXCHANGE PROGRAMS; UNITED STATES;

EID: 0032516537     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. CDC. HIV/AIDS surveillance report, 1997. Atlanta, Georgia. US Department of Health and Human Services, Public Health Service, 1997. Vol 9, no. 2).
2. CDC. Syringe exchange programs - United States, 1994-1995. MMWR 1995;44:684-5,691.
3. CDC. Update: Syringe exchange programs - United States, 1996. MMWR 1997;46:565-8.
4. Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: how many injections take place annually and how might pharmacists contribute to syringe distribution? J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(suppl 1):S126-S132.
5. Bruneau J, Lamothe F, Lachance N, et al. Injection behaviors in HIV seroconversion among IV drug users in Montreal. Geneva, Switzerland: Presented at the XII International Conference on AIDS, June 28-July 3, 1998. (Abstract 23221).
6. Schechter M, Strathdee SL, Currie DM, et al. Harm reduction, not harm production: needle exchange does not promote HIV transmission among injection drug users in Vancouver, Canada. Geneva, Switzerland: Presented at the XII International Conference on AIDS, June 28-July 3, 1998. (Abstract 33379).
7. Heimer R, Khoshnood K, Bigg D, Guydish J. Syringe use and re-use: effects of needle exchange programs in three cities. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(suppl 1):S37-S44.
8. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programs. Lancet 1996;348:987-91.
9. Brooner R, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep 1998;113(suppl 1):129-39.
10. Jones TS, Vlahov D. Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(suppl 1):S1-S5.